Safety and Efficacy of T8 on Treating Chronic Abnormal Immune Activation in HIV/AIDS Patients
Clinical trial NCT04084444 · COMPLETED
Trial details
- NCT number
- NCT04084444
- Sponsor
- Shanghai Pharmaceuticals Holding Co., Ltd
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2019-12-25
- Primary completion
- 2022-07-05
- Enrollment
- 151
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.